Advanced Search

 

Study ID Status Title Patient Level Data
ZOV30008 Completed A Phase III Multicentre, Double-Blind, Active-Controlled, Parallel Study Comparing the Efficacy and Safety of ZOVIRAX Cold Sore Cream (Aciclovir 5% Cream) and Lidocaine 2% to ZOVIRAX Cold Sore Cream Alone Administered for 5 Days in Subjects with Herpes Labialis Infection.
ZOV30009 Completed A Phase III Multicentre, Double-Blind, Active-Controlled, Parallel Study Comparing the Efficacy and Safety of ZOVIRAX Cold Sore Cream (Aciclovir 5% Cream) and Lidocaine 2% to ZOVIRAX Cold Sore Cream Alone Administered for 5 Days in Subjects with Herpes Labialis Infection.
ZVC111449 Completed Bioequivalence study of Aciclovir 5% cream - Bioequivalence study of Aciclovir cream between Current and New formulation in Japanese Healthy volunteers -
ZVX10001 Completed Skin Safety Study of Aciclovir Cream 5%
ZYB 30011 Completed A multicentre, randomised, double- blind, placebo controlled study to evaluate the efficacy and tolerability of bupropion hydrochloride (SR) sustained release (2 x 150mg per day) versus placebo as an aid to smoking cessation in smokers with at least one cardiovascular (CV) risk factor.
ZYB30005 Completed An open-label, multicentre study with general practitioners to assess efficacy and safety of Bupropion SR (2x150mg) dependent on (sub)-depression and motivation
ZYB30009 Completed A multi-centre, randomised, double-blind, placebo controlled, 6 month study to evaluate the efficacy and tolerability of bupropion hydrochloride sustained release tablets for the treatment of nicotine dependence as an aid to smoking cessation in a healthcare professionals and hospital staff popu ...
ZYB40001 Completed A randomized, double-blind, placebo-controlled, 12-week smoking cessation trial of Zyban (150 mg bid) in adult smokers previously treated with Zyban
ZYB40003 Completed A multicenter, randomized, parallel, placebo-controlled, one-year study of the efficacy and safety of bupropion hydrochloride sustained-release tablets versus placebo as an aid to smoking cessation treatment in adult cigarette smokers previously treated with bupropion Study Listed on ClinicalStudyDataRequest.com
ZYB40005 Completed The effect of sustained-release bupropion HCl vs. placebo as an aid to smoking reduction leading to cessation among smokers unwilling and unable to quit smoking Study Listed on ClinicalStudyDataRequest.com
ZYB40011 Completed A multi-centre, randomised, double-blind, placebo-controlled, one-year study to evaluate the efficacy and tolerability of bupropion hydrochloride (SR) (sustained release tablets) for the treatment of nicotine dependence as an aid to smoking cessation in population of healthcare professionals.
ZYB40014 Completed A multi-center, randomised, parallel-group, double-blind, placebo-controlled one year study (with a 7 week Treatment Phase) to evaluate the efficacy and tolerability of bupropion hydrochloride (SR) versus placebo as an aid to smoking cessation in a population of smokers with established, stable cardiovascular disease Study Listed on ClinicalStudyDataRequest.com
ZYB40017 Completed A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, One-Year Study to Evaluate the Efficacy and Safety of Bupropion Hydrochloride (SR) (Sustained-Release Tablets) for the Treatment of Nicotine Dependence as an Aid to Smoking Cessation.
ZYB40021 Completed A 6 Month Multicenter, Randomized, Double-Blind, Pilot Study to Investigate the Tolerability and Efficacy of Bupropion SR Compared to Placebo for the Treatment of Mild Depressive Symptoms and Obesity, Followed by a 24-week Open-Label Extension Study Listed on ClinicalStudyDataRequest.com
ZYB40030 Completed A multi-centre, randomised, double-blind, placebo controlled study to evaluate the efficacy and tolerability of bupropion hydrochloride (SR) sustained release versus placebo as an aid to smoking cessation in a population of smokers with Chronic Obstructive Pulmonary Disease.
ZYB40033 Completed A multi-centre, open, one-year study to evaluate the efficacy and safety of bupropion hydrochloride (sustained release tablets) for the treatment of nicotine dependence as an aid to smoking cessation in a population of smokers either without any medical condition, with chronic obstructive pulmon ...
ZYB40036 Completed A single-country, multi-centre, open-label study to evaluate the efficacy and tolerability of bupropion hydrochloride (SR) (sustained release tablets) for the treatment of nicotine dependence as an aid to smoking cessation in patients with chronic bronchitis.
ZYB40041 Completed An open-label, multicentre study with general practitioners to assess efficacy and safety of Bupropion SR (2x150mg per day) as an aid to smoking cessation in patients who were previously treated with Bupropion SR or NRT
ZYB40045 Completed An open one year study to evaluate the efficacy and safety of bupropion hydrochloride (Quomen) for smoking cessation in smokers with mild to moderate chronic obstructive pulmonary disease (COPD)
ZYBAKIA402 Completed A single center evaluation of Wellbutrin (bupropion hydrochloride) versus placebo as an aid to smoking cessation (study 402)
ZYBF4001 Completed Evaluation of efficacy of safety of ZybanTM (bupropion hydrochloride extended release tablet) in smoking cessation aid in nicotine-dependent patients. Multicentre, randomized, double blind, placebo-controlled study, 6 months length.
ZYBPL01 Completed Efficacy and safety of Bupropion ( Zyban, GlaxoSmithKline ) for the treatment of smoking cessation in patients with chronic bronchitis.

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.